An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT02186769 · COMPLETED
Trial details
- NCT number
- NCT02186769
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-04-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.